top of page
Browse by category
Search


IFSO Bariatric Endoscopy Committee endorses endoscopic sleeve gastroplasty as an effective and valuable treatment for obesity
The IFSO Bariatric Endoscopy Committee has endorsed endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for...


BMS reduces obesity-related pregnancy complications but introduces potential risks that may result in adverse outcomes
Whilst bariatric and metabolic surgery (BMS) can reduce obesity-related pregnancy complications, it can inadvertently result in an...


Anaemia remains a significant condition ten years after bariatric surgery
Anaemia remains a significant but still manageable condition five and ten years after bariatric surgery, but despite the prescription of...


Ascletis' announces promising results for ASC47 adipose-targeted THRβ
Ascletis Pharma has announced that results of its Phase I single ascending dose (SAD) study in Australia in subjects with elevated...


BMS may help reduce heart failure-related risk factors
Metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage...


GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour
Patients on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - Victoza (Liraglutide 1.8mg), Saxenda (Liraglutide 3mg), Ozempic...


Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours
The majority of participants experience changes in taste perception, desire, and enjoyment of flavours after undergoing sleeve...

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss
Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...

Journal Watch 6/11/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Omada survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals
Omada Health has released findings from an attitudinal survey of 1,000 non-Omada members to better understand the needs of consumers...
Browse by tag





bottom of page